Literature DB >> 29884783

Author Correction: A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.

Alison Roth1, Steven P Maher1,2, Amy J Conway1, Ratawan Ubalee3, Victor Chaumeau4,5, Chiara Andolina4,5, Stephen A Kaba6, Amélie Vantaux7, Malina A Bakowski8, Richard Thomson-Luque1, Swamy Rakesh Adapa1, Naresh Singh1, Samantha J Barnes1, Caitlin A Cooper2, Mélanie Rouillier9, Case W McNamara8, Sebastian A Mikolajczak10, Noah Sather10, Benoît Witkowski8, Brice Campo9, Stefan H I Kappe10, David E Lanar6, François Nosten4,5, Silas Davidson3, Rays H Y Jiang1, Dennis E Kyle1,2, John H Adams11.   

Abstract

The original version of this Article contained an error in the spelling of Richard Thomson-Luque, which was incorrectly given as Richard Thomson Luque. This error has now been corrected in both the PDF and HTML versions of the Article.

Entities:  

Year:  2018        PMID： 29884783      PMCID： PMC5993793          DOI： 10.1038/s41467-018-04817-1

Source DB:  PubMed          Journal:  Nat Commun        ISSN： 2041-1723            Impact factor:   14.919


Correction to: Nature Communications 10.1038/s41467-018-04221-9, published online 09 May 2018. The original version of this article contained an error in the spelling of Richard Thomson-Luque, which was incorrectly given as Richard Thomson Luque. This error has now been corrected in both the PDF and HTML versions of the Article.
  3 in total

Review 1.  Home Sweet Home: Plasmodium vivax-Infected Reticulocytes-The Younger the Better?

Authors:  Richard Thomson-Luque; José M Bautista
Journal:  Front Cell Infect Microbiol       Date:  2021-05-13       Impact factor: 5.293

2.  Structural basis of Plasmodium vivax inhibition by antibodies binding to the circumsporozoite protein repeats.

Authors:  Iga Kucharska; Lamia Hossain; Danton Ivanochko; Qiren Yang; John L Rubinstein; Régis Pomès; Jean-Philippe Julien
Journal:  Elife       Date:  2022-01-13       Impact factor: 8.140

3.  Plasmodium vivax latent liver infection is characterized by persistent hypnozoites, hypnozoite-derived schizonts, and time-dependent efficacy of primaquine.

Authors:  Erika L Flannery; Niwat Kangwanrangsan; Vorada Chuenchob; Wanlapa Roobsoong; Matthew Fishbaugher; Kevin Zhou; Zachary P Billman; Thomas Martinson; Tayla M Olsen; Carola Schäfer; Brice Campo; Sean C Murphy; Sebastian A Mikolajczak; Stefan H I Kappe; Jetsumon Sattabongkot
Journal:  Mol Ther Methods Clin Dev       Date:  2022-08-02       Impact factor: 5.849
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.